- Poster presentation
- Open Access
0734. Early changes in heart rate predict long-term survival in a rodent model of sepsis
© Rudiger et al; licensee Springer. 2014
- Published: 26 September 2014
- Heart Rate
- Abdominal Sepsis
- Septic Animal
In sepsis, early prognostication of outcome would be helpful both for the detection of underlying mechanisms (adaptive vs. maladaptive) and the development of novel treatments for potential non-survivors.
We tested whether telemetry derived heart rate (HR) changes during early sepsis could prognosticate outcome in a long-term rat model of fecal peritonitis.
Male Wistar rats were instrumented with telemetry for continuous HR and temperature recording. Abdominal sepsis was induced by intraperitoneal injection of fecal slurry. A jugular catheter allowed the intravenous administration of opioids (nalbuphin 1mg/kg/h), antibiotics (rocephin 30mg/kg at 4 and 24h) and crystalloids (bolus of 20ml/kg at 4h, followed by an infusion of 10ml/kg/h, halved after 8 and 24h). The awake animals were followed for 48 hours.
Heart rate (bpm) in survivors and non-survivors:
4 h after septic insult
6 hours post septic insult
Change BL to 4 hours
ROC analysis revealed that the change in HR between baseline and 4h was a good prognosticator (AUC 0.84, 95% CI 0.56-1.00; p=0.03). An increase in HR of ≥50 bpm between baseline and 4 hours separated survivors and non-survivors with a sensitivity and specificity of 80% and 100%, respectively.
In this clinically relevant rat model of abdominal sepsis changes in HR as early as 4 hours after the septic insult predicted outcome with good sensitivity and excellent specificity. This will allow future investigation of adaptive changes in potential survivors and mechanisms of death in potential non-survivors. In addition, novel sepsis-treatments (e.g. beta-blockers) can be tested in regards of their beneficial and harmful effects in potential non-survivors and survivors.
ESICM ECCRN Established Investigator Award 2011 to Alain Rudiger
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.